Article Information
History
- June 27, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Alfredo Dueñas Rey1,2,
- Marta del Pozo Valero1,2,3,*,
- Manon Bouckaert1,2,*,
- Filip Van Den Broeck4,5,
- Malena Daich Varela6,7,
- Mattias Van Heetvelde1,2,
- Marieke De Bruyne1,2,
- Stijn Van de Sompele1,2,
- Miriam Bauwens1,2,
- Jamie Ellingford8,9,10,
- Hanne Lenaerts1,2,
- Quinten Mahieu1,2,
- Dragana Josifova11,
- Genomics England Research Consortium10,
- Carlo Rivolta12,13,14,
- Andrew Webster6,7,
- Gavin Arno6,7,
- Carmen Ayuso3,15,
- Julie De Zaeytijd4,5,
- Bart P. Leroy1,4,5,16,
- Elfride De Baere1,2 and
- Frauke Coppieters1,2,17,#
- 1Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium
- 2Department of Biomolecular Medicine, Ghent University, Ghent, Belgium
- 3Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM)
- 4Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium
- 5Department of Head & Skin, Ghent University, Ghent, Belgium
- 6UCL Institute of Ophthalmology, London, UK
- 7Moorfields Eye Hospital, London, UK
- 8Division of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicines and Health, University of Manchester, Manchester, UK
- 9Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK
- 10Genomics England, London, UK
- 11Clinical Genetics Department, Guy’s Hospital, London, UK
- 12Department of Ophthalmology, University of Basel, Basel, Switzerland
- 13Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland
- 14Department of Genetics and Genome Biology, University of Leicester, Leicester, UK
- 15Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
- 16Division of Ophthalmology & Center for Cellular & Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
- 17Department of Pharmaceutics, Ghent University, Ghent, Belgium
- ↵#Corresponding author: Frauke Coppieters (frauke.coppieters{at}ugent.be)
Posted June 27, 2023.
Combining a prioritization strategy and functional studies nominates 5’UTR variants underlying inherited retinal disease
